Table I.
Associations between CASC9 expression and clinicopathological characteristics of bladder cancer patients.
| Expression of CASC9 | ||||
|---|---|---|---|---|
| Characteristics | Total | High (n=39) | Low (n=10) | P-value |
| Sex | 0.069 | |||
| Male | 40 | 34 | 6 | |
| Female | 9 | 5 | 4 | |
| Tumor size (cm) | 0.719 | |||
| <4 | 19 | 16 | 3 | |
| ≥4 | 30 | 23 | 7 | |
| Age (years) | 0.029 | |||
| ≤60 | 22 | 14 | 8 | |
| >60 | 27 | 25 | 2 | |
| Tumor invasion depth (T) | 0.025 | |||
| Tis, Ta, T1 | 18 | 11 | 7 | |
| T2, T3 or above | 31 | 28 | 3 | |
| TNM stage | 0.247 | |||
| 0/I | 15 | 10 | 5 | |
| II/III/IV | 34 | 29 | 5 | |
TNM was according to the seventh edition of staging TNM of the Union for International Cancer Control (UICC) in 2009. Chi-square test was used to assess the association between two categorical variables. CASC9, cancer susceptibility candidate 9.